Leveraging the Power of Vacuum Ultraviolet (VUV) Detection to Improve Laboratory Efficiency

This event is now available on demand.

Event Overview:

In today’s modern pharmaceutical laboratory there are a wide variety of analytical techniques and methods used in the typical workflow. Moisture analysis is often carried out using Karl Fisher Titration, residual solvents in API’s are analyzed with GC-FID, and genotoxic impurities are analyzed with any number of techniques including mass spectrometry. Managing and maintaining all these analytical tools and methods requires a significant amount of effort. What if you could combine many of these analyses into a single run, potentially eliminating the need for some of these techniques? What impact would that have on laboratory efficiency?

This webinar will introduce attendees to an innovative new detector the LUMA™ Multi-channel VUV absorbance detector along with its unique capabilities. Through a series of examples attendees will learn how this new detector can be leveraged to run a wide variety of methods and how those methods can be combined into a single analysis—potentially simplifying GC workflows, reducing operational costs, improving accuracy, and supporting sustainability objectives.

Key Learning Objectives:
  • History and theory behind vacuum ultraviolet detection for GC
  • Importance of VUV over other more complicated detection methods for today’s laboratory
  • Understand how the LUMA multi-channel VUV absorbance detector allows you to combine many multiple applications into a single analysis.
Who Should Attend: 
  • Laboratory managers interesting in simplifying GC workflows and improving efficiency

Featured Speaker:

Dr. Richard Ladd
Dr. Richard Ladd
Principal
RML Consulting


Richard Ladd is a senior Leader and owner and Director of RML Consulting. An independent consultant to the pharmaceutical industry specializing in pharmaceutical development, manufacture, and new technology innovation. With more than 35 years Pharmaceutical industrial experience of all stages of new drug discovery, development, scale-up, manufacture, supply, and commercialization.

Richard has an extensive track record of delivering in scientific, line and project leadership roles across Pharmaceutical R&D, regulatory CMC, the analytical instrument industry and at the Interface of academia and the public sector. He has extensive expertise in analytical, pharmaceutical development and regulatory CMC authoring and reviewing regulatory submissions from first-in-human to NDA/MAA as well as defending regulatory submissions and conducting prep-approval audit inspections of both manufacturing and analytical facilities. In addition, he has a passion for new technology development and adoption and is an impeccable technical problem solver with a proven track record of solving many commercially significant problems.

Richard has extensive experience of the EU, US, China, Japan, India, and other emerging markets. He is highly active, networked, and influential across an extensive portfolio of academic, industrial, healthcare, public sector and policy related matters.

Richard is a lucid communicator who sets and provides clarity on strategic direction, tenacious, delivery focused, challenges the status quo, affects change, and drives improvement.

Richard regularly presents at international meetings most recently on the subjects supporting quality by design strategies with technology solutions in pharmaceuticals, technology adoption for technical trouble shooting and driving efficiency and productivity to shorten development times by utilizing novel technological solutions.

Speaker’s Email: Richard.ladd@rmlconsulting.co.uk
Speaker’s LinkedIn: linkedin.com/in/dr-richard-ladd-96666762


For any technical questions please contact Nicole Valle: nvalle@mjhevents.com